Harmonized System
U.S. exports of Hormone-Containing Medicaments (Not in Dosage Form, No Antibiotics) (HS 300339) totaled $29.3M in August 2026.
Hormone-Containing Medicaments (Not in Dosage Form, No Antibiotics) imports of $1.6M in August 2026 ran 89% below the year-to-date monthly average of $14.1M.
Last updated: August 2026 dataBulk hormone-based pharmaceutical preparations — including artificial mixtures of natural hormones and other products of HS heading 2937 — enter the US under three distinct tariff lines (3003390000, 3003391000, 3003395000), allowing customs to differentiate synthetic, natural-mixture, and residual hormone formulations at the 10-digit level. Denmark and Belgium lead supply, with India, Italy, and Japan also significant sources, reflecting the global dispersion of active pharmaceutical ingredient (API) and intermediate manufacturing. Because these products are not yet in retail dosage form, they typically move through pharmaceutical supply chains as APIs or semi-finished goods destined for further domestic processing. FDA registration of the foreign establishment and compliance with cGMP standards are mandatory entry requirements.
AI-written summary of the official U.S. Census Bureau trade figures on this page — verify before relying on it.
11 import shipments a month
The US schedule carves out artificial mixtures of natural hormones into their own 10-digit line (3003391000), separate from the broader catch-all for hormone medicaments (3003395000). The distinction turns on whether the active substance is a defined mixture of naturally occurring hormones versus a synthetic hormone or other product of heading 2937. Importers should confirm the precise chemical identity and mixture composition with their supplier to avoid misclassification.
Certain pharmaceutical intermediates and APIs from China may be subject to Section 301 tariffs depending on the specific product and tariff line. Importers sourcing from China should verify current Section 301 applicability for the relevant 10-digit HTS code before finalizing pricing. Consult a licensed customs broker for the current status of any applicable measures.
Subheading 2 of 10 in heading 3003
Subheading 300339 · $29.3M of $139.8M
Trade Directory
List your company under HS 300339 — Hormone-Containing Medicaments (Not in Dosage Form, No Antibiotics), so the companies trading it can find you. Be the first supplier listed.
HS10 import codes under this HS6 parent, each with its own page. Source: U.S. Harmonized Tariff Schedule.
| Code | Description | Imports for consumption | Average duty rate | Dutiable Share |
|---|---|---|---|---|
| 3003395000 | Other Medicaments Containing Hormones Etc | $945K | 0.00% | 0.00% |
| 3003391000 | Artificial Mixtures of Natural Hormones | $621K | 0.00% | 0.00% |
HS10 export codes under this HS6 parent, each with its own page. Source: U.S. Schedule B export classification.
| Code | Description | Export Value |
|---|---|---|
| 3003390000 | Medicament Cont Hormones or Prod of Hd 2937 Etc | $29.3M |
Import lines come from the U.S. Harmonized Tariff Schedule and export lines from Schedule B. The two are numbered by different agencies, so the same 10-digit code can appear in both tables describing a different product.
ImportsExports
Imports
$1.6MYoY · free account
Exports
$29.3MYoY · free account
12-mo low · imports
Low · free accountOver the twelve months to August 2026, the U.S. imported $162.9M of Hormone-Containing Medicaments (Not in Dosage Form, No Antibiotics) and exported $211.7M.
Through August 2026. Source: U.S. Census Bureau.
Exports · August 2026
destination
Denmark and Ireland together take 69% of it.
customs district
origin
entry
rate provision · imports
100.0% enters free of duty; duty collected equals 0.00% of imports for consumption.